期刊文献+

消化系统肿瘤组织细胞来源及临床分期/病理类型与化疗药物敏感性的关系研究 被引量:7

Correlation of sensitivity of chemotherapy drugs with the originated tissue, clinical stage and pathological type of carcinoma
下载PDF
导出
摘要 目的从肿瘤组织学来源、临床病理分期及病理类型角度,探讨肿瘤细胞与化疗药物敏感性的相关性,指导临床化疗。方法通过肿瘤细胞体外药敏试验———四甲基偶氮唑盐(MTT)着色法,对480例消化系统肿瘤新鲜标本进行化疗药物敏感性检测,分析不同组织学来源、临床病理分期及病理类型肿瘤细胞与化疗药物敏感性的相关性。结果(1)4种不同肿瘤细胞对丝裂霉素(MMC)及5氟脲嘧啶(5FU)+顺铂(CDDP)的敏感性无显著性差异(P>0.05),对其余所有药物的敏感性均有显著性差异(P<0.05)。(2)在临床分期中,食管癌肿瘤细胞对阿霉素(ADM)的敏感性无显著性差异(P>0.05),其余肿瘤细胞对所有药物的敏感性均有显著性差异(P<0.05)。(3)在胃癌和大肠癌不同病理组织学类型中,肿瘤细胞对所有药物的敏感性均有显著性差异(P<0.05)。结论不同组织学来源的肿瘤细胞对化疗药物的敏感性不同。肿瘤细胞对化疗药物的敏感性与肿瘤的临床病理分期、病理组织学类型密切相关,分期越晚,分化程度越高,肿瘤细胞对化疗药物的敏感性越高。 Objective To study the correlation of originated tissue, clinical stage and pathological type of carcinoma between sensitivity of chemotherapy drugs with tumor cells,in order to guide clinical chemotherapy on patients with tumors.Methods 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide(MTT) test was used to determine the sensitivity of chemotherapy drugs on the survival tumor specimens of 480 patients with cancer from esophagus, stomach, liver or colorectal. Its difference of the sensitivity of chemotherapy drugs was compared with the originated tissues, clinical stage and pathological type of these specimens.Results (1)In this group of cancer cells of variant tissue, there was a statistical significance difference between the sensitivity of all chemotherapy drugs and cancer cells(P<0.05), excepted MMC and 5-FU combined CDDP(P>0.05).(2)In clinical stage, the statistical significance difference between the sensitivity of all chemotherapy drugs and cancer cells(P<0.05) was shown, excepted ADM in clinical stage of esophagus cancer (P>0.05).(3)In this group of variant pathological type of these stomach and colorectal cancer, the difference had statistical significance between the sensitivity of all chemotherapy drugs and cancer cells(P<0.05).Conclusion The results shows that the sensitivity of chemotherapy drugs is correlated with variant clinical stage and pathological type. The sensitivity of chemotherapy drugs gradually increased from Ⅰ stage to Ⅳ stage. The sensitivity of chemotherapy drugs decrease with differentiation reduction of cancer cells.
出处 《国外医学(临床生物化学与检验学分册)》 2005年第4期209-212,216,共5页 Foreign Medical Sciences(section of Clinical Biochemistry and Laboratory Medicine
基金 四川省卫生厅2001~2004年度科学基金资助课题[川卫科教发2001(41)]
  • 相关文献

参考文献4

二级参考文献4

共引文献43

同被引文献29

  • 1王彩莲,陈宝安.多西紫杉醇治疗晚期胃癌的进展[J].现代医学,2005,33(1):53-55. 被引量:20
  • 2李连勇,刘庆森.胃癌化疗方案及策略进展[J].肿瘤防治研究,2006,33(7):536-539. 被引量:8
  • 3魏宇宁,高丽丽,杨亚青.MTT法测定紫杉醇与奥沙利铂在不同分化程度胃腺癌细胞株中的敏感性[J].中国药房,2007,18(4):267-268. 被引量:1
  • 4张强,张宾,李新霞,高松.MTT比色法检测贲门中分化腺癌化疗药物敏感性评价[J].泰山医学院学报,2006,27(7):635-636. 被引量:2
  • 5Yeh KH, Lu YS, Hsu CH, et al. Phase Ⅱ study of weeklypaclitaxel and 24- hour infusion of high- dose 5- fluorouracil and leucovorin in the treatment of recur-rent or metastatic gastric cancer[J]. Oncology, 2005, 69(1 ): 881.
  • 6Jeung HC, Rha SY, Kim YT, et al. Aphase Ⅱ study of infusional 5- fluorouracil and low- dose leucovorinwith docetaxel for advanced gastric cancer [ J ]. Oncology, 2006, 70 ( 1 ) : 631.
  • 7Lee E, Shelden EA, Knecht DA. Changes inactin filament organization during pseudopod formation[J]. Exp Cell Res, 1997, 235 (1) : 295 - 299.
  • 8Kubota T, Egawa T, Otani Y, et al. Chemotherapy chemosensitivity testing is useful in evaluating the appropriate adjuvant cancer chemotherapy for stages Ⅲ/Ⅳ gastric cancers without peritoneal dissemination[J]. Anticancer Res, 2003, 23:583 - 587.
  • 9Park YN, Chae KJ, Kim YB, et al. Apoptosis and proliferation in hepatocarcinogenesis related to cirrhosis [ J ]. Cancer, 2001,92 (11):2733 -8.
  • 10Yamada Y, Shirao K, Ohtsu A, et al. Phase Ⅱ trial of paclitaxel by three hour infusion for advanced gastric cancer with short premidieation for prophylaxsagaunst paclitaxel associated hypersensitivity reactions[J]. Ann Oncol,2001,12(6) ;1133 -7.

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部